Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Role of adenylyl cyclase 6 in the development of lithium-induced nephrogenic diabetes insipidus
Søren Brandt Poulsen, Tina Bøgelund Kristensen, Heddwen L. Brooks, Donald E. Kohan, Timo Rieg, Robert A. Fenton
Søren Brandt Poulsen, Tina Bøgelund Kristensen, Heddwen L. Brooks, Donald E. Kohan, Timo Rieg, Robert A. Fenton
View: Text | PDF
Research Article Cell biology

Role of adenylyl cyclase 6 in the development of lithium-induced nephrogenic diabetes insipidus

  • Text
  • PDF
Abstract

Psychiatric patients treated with lithium (Li+) may develop nephrogenic diabetes insipidus (NDI). Although the etiology of Li+-induced NDI (Li-NDI) is poorly understood, it occurs partially due to reduced aquaporin-2 (AQP2) expression in the kidney collecting ducts. A mechanism postulated for this is that Li+ inhibits adenylyl cyclase (AC) activity, leading to decreased cAMP, reduced AQP2 abundance, and less membrane targeting. We hypothesized that Li-NDI would not develop in mice lacking AC6. Whole-body AC6 knockout (AC6–/–) mice and potentially novel connecting tubule/principal cell–specific AC6 knockout (AC6loxloxCre) mice had approximately 50% lower urine osmolality and doubled water intake under baseline conditions compared with controls. Dietary Li+ administration increased water intake and reduced urine osmolality in control, AC6–/–, and AC6loxloxCre mice. Consistent with AC6–/– mice, medullary AQP2 and pS256-AQP2 abundances were lower in AC6loxloxCre mice compared with controls under standard conditions, and levels were further reduced after Li+ administration. AC6loxloxCre and control mice had a similar increase in the numbers of proliferating cell nuclear antigen–positive cells in response to Li+. However, AC6loxloxCre mice had a higher number of H+-ATPase B1 subunit–positive cells under standard conditions and after Li+ administration. Collectively, AC6 has a minor role in Li-NDI development but may be important for determining the intercalated cell–to–principal cell ratio.

Authors

Søren Brandt Poulsen, Tina Bøgelund Kristensen, Heddwen L. Brooks, Donald E. Kohan, Timo Rieg, Robert A. Fenton

×

Figure 1

Li+ reduces urine osmolality and increases water intake in AC6–/– and WT mice.

Options: View larger image (or click on image) Download as PowerPoint
Li+ reduces urine osmolality and increases water intake in AC6–/– and WT...
Following an initial baseline period on standard diet, mice lacking adenylyl cyclase 6 (AC6–/–) and WT mice were fed a Li+-containing diet for 27 days, during which physiological parameters were measured. (A) Urine osmolality (osm), (B) water intake, (C) urine osmolality relative to baseline conditions (percentage of baseline), and (D) water intake relative to baseline conditions (percentage of baseline). Baseline values are averages of the last 5–7 days before switching from standard diet to Li+ diet. Sample size for urine osmolality: AC6–/–, n = 5–8; WT, n = 6–8. Sample size for water intake: AC6–/–, n = 3–5; WT, n = 4. Values are mean ± SEM. All statistical comparisons were performed using 2-way repeated-measurements ANOVA followed by Holm-Sidak post-hoc tests. *P < 0.05, baseline versus Li+ administration; #P < 0.05, AC6–/– versus WT at individual days.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts